abbokinase-open-cath and Acetylsalicylic acid Interactions

Interactions between abbokinase-open-cath(urokinase) and Acetylsalicylic acid (aspirin)

aspirin and urokinase (Moderate Drug-Drug)

MONITOR: Drugs that inhibit platelet function may increase the risk of bleeding when administered prior to, during, or after thrombolytic therapy.

MANAGEMENT: Careful monitoring for signs of bleeding, particularly at arterial puncture wounds, is recommended when thrombolytics are used concurrently or sequentially with antiplatelet agents.